查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1935640

气喘监测设备市场按产品类型、技术、通路、电源、应用、年龄层和最终用户划分，全球预测，2026-2032年

Asthma Monitoring Devices Market by Product Type, Technology, Distribution Channel, Power Source, Application, Age Group, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，气喘监测设备市场价值将达到 20.5 亿美元，到 2026 年将成长至 22.2 亿美元，到 2032 年将达到 37.3 亿美元，复合年增长率为 8.94%。

关键市场统计数据
基准年 2025 20.5亿美元
预计年份：2026年 22.2亿美元
预测年份 2032 37.3亿美元
复合年增长率 (%) 8.94%

本文权威概述了数位感测技术、日益严格的监管以及不断变化的医疗服务模式如何重塑气喘监测设备的临床和消费者使用方式。

气喘监测设备如今已成为临床需求、数位创新和消费者健康参与三者交会的焦点。感测技术、连接通讯协定和以使用者为中心的设计的快速发展，重新定义了临床医生和患者监测呼吸功能和管理慢性疾病的方式。在药物依从性和早期发现直接影响临床结果的环境下，智慧吸入器和穿戴式监测器等设备不再是辅助设备，而是成为诊疗路径中不可或缺的一部分。

感测器小型化、智慧型手机整合、远端医疗优先发展以及数据管治将如何从根本上重塑气喘监测价值链

由于技术、医疗服务模式和患者期望三方因素的共同作用，气喘监测设备领域正经历变革性的转变。微型感测器和低功耗无线通讯协定的进步催生了新一代设备，这些设备能够在最大限度减轻用户负担的同时，持续收集生理数据。同时，智慧型手机整合和云端分析技术的进步，使得趋势检测、自动警报以及与电子健康记录的整合成为可能，从而提升了设备生成数据的实用价值。

评估2025年关税调整如何重塑气喘监测设备生态系统的供应链、采购计算与供应商策略

2025年实施的累积关税措施对医疗设备供应链和筹资策略产生了即时且连锁的影响。依赖跨境采购电子元件、机壳和感测器的製造商面临投入成本增加和前置作业时间延长的双重挑战。为此，一些公司寻求供应商多元化并加快供应商资质认证流程，而另一些公司则重新评估了国内生产与海外成本优势之间的权衡。

深度細項分析揭示了产品类型、连接偏好、通路、电源设计、临床应用、年龄层和最终用户采用路径如何决定采用路径

对设备类别和部署环境的详细分析揭示了产品、技术、分销、电源、应用、人口统计和最终用户等各个细分领域的清晰采用趋势。产品类型涵盖电子气喘监测仪、尖峰流量计、脉动式血氧监测仪系统、智慧吸入器、肺计量计以及穿戴式监测设备。在穿戴式装置领域，心率、血氧饱和度和呼吸频率感测器可满足不同的临床应用情境和不同的检验要求。这些设备越来越多地采用互联架构或智慧型手机整合模型。互联类别又可细分为蓝牙、蜂窝网路和 Wi-Fi 通讯技术，每种技术都会影响互通性、资料延迟和电力消耗。

区域比较分析揭示了法规结构、支付模式、製造能力和医疗保健优先事项如何影响世界各地医疗器材的普及应用。

区域趋势将对美洲、欧洲、中东和非洲以及亚太地区的监管路径、报销模式和普及速度产生重大影响。在美洲，强大的医院网络和支付方对基于价值的医疗服务日益增长的兴趣正在加速对能够展现临床效用并支持远端系统管理的设备的需求，而私营部门的创新生态系统则在推动消费级设备的开发。从早期采用者到更广泛的机构采用的转变通常取决于证据的产生以及与医疗服务提供者IT系统的整合。

竞争格局分析凸显了临床可靠性、数位化优先的参与企业、伙伴关係和服务导向模式如何重新定义差异化和规模化扩大策略。

气喘监测设备市场的竞争格局呈现出多元化的特点，既有成熟的医疗设备製造商，也有敏捷的数位医疗Start-Ups公司，还有整合硬体、软体和服务的垂直整合型企业。现有企业凭藉其临床信誉、监管经验和成熟的分销网络，与医院和诊断中心保持良好的合作关係。同时，新参与企业则专注于使用者体验、快速的产品改进和云端分析，以吸引消费者和门诊病人的注意。

为医疗设备製造商和医疗系统领导者建构临床可靠性、互通性、弹性供应链和灵活的商业模式提供切实可行、优先考虑和具有战略意义的步骤。

产业领导者应采取一系列切实可行的措施，将技术潜力转化为持续的临床和商业性成果。首先，应优先在具有代表性的患者群体中进行严格的临床检验，以建立与临床医生和支付方的信任。应投资进行前瞻性研究和真实世界证据收集，重点关注药物依从性、病情恶化预防和护理协调指标。其次，应设计互通性的设备平台，透过采用开放标准和提供完善的API文檔，促进与电子健康记录和远端医疗服务的整合。

我们采用透明、多维度的研究途径，整合相关人员访谈、临床检验审查、技术评估和供应链情境分析，以确保获得严谨的洞见。

本研究整合了初级研究和二级研究，并采用系统性的证据和品质保证方法。初级研究资料包括对临床负责人、采购专业人员、器械工程师和支付方代表的访谈，并辅以对器械规格、监管申报文件和产品文献的技术评估。二级资讯来源包括同行评审的临床研究、监管指导文件和公开的产品讯息，并对这些数据进行三角验证，以检验器械功能和典型部署场景。

综合分析表明，检验的感测技术、互通性、供应链韧性和协调一致的商业模式是永续应用和临床影响的基础。

总之，气喘监测设备正处于关键的转折点。技术能力的提升、临床对远端系统管理的需求以及不断变化的采购趋势，共同为製造商、医疗服务提供者和支付方创造了新的机会和挑战。具备检验的感测技术、无缝连接和显着临床效用的设备将成为医疗机构的首选。同时，面向消费者的解决方案必须在易用性和临床数据的可靠性之间取得平衡。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的气喘监测设备市场

  • 电子气喘监测仪
  • 峰值流量计
  • 脉动式血氧监测仪系统
  • 智慧吸入器
  • 肺计量计
  • 穿戴式监测设备
    • 心率感测器
    • 氧饱和度感测器
    • 呼吸频率感测器

第九章 依技术分類的气喘监测设备市场

  • 连接类型
    • Bluetooth
    • 细胞
    • Wi-Fi
  • 内建智慧型手机

第十章 按分销通路分類的气喘监测设备市场

  • 直销
  • 医院药房
  • 网路药房
  • 零售药房
    • 店铺
    • 网路市集

第十一章气喘监测设备市场（依来源划分）

  • 电池供电
  • 插座连接类型
  • 可充电的

第十二章 按应用分類的气喘监测设备市场

  • 气喘诊断支持
  • 每日症状追踪
  • 药物依从性监测
  • 肺功能监测
  • 远端患者监护（RPM）

第十三章 按年龄组别分類的气喘监测设备市场

  • 成人
  • 老年人
  • 儿童

第十四章 依最终用户分類的气喘监测设备市场

  • 门诊手术中心（ASC）
  • 诊断检查室
  • 居家医疗环境
  • 医院和诊所
  • 研究和学术机构

第十五章气喘监测设备市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 按组别分類的气喘监测设备市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国气喘监测设备市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

18. 美国气喘监测设备市场

第十九章 中国气喘监测设备市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Adherium Limited
  • Amiko Digital Health Limited
  • AptarGroup, Inc.
  • AstraZeneca plc
  • FindAir
  • Health Care Originals, Inc.
  • Koninklijke Philips NV
  • Masimo Corporation
  • MGC Diagnostics Corporation
  • Microlife Corporation
  • Nihon Kohden Corporation
  • Novartis AG
  • Omron Healthcare, Inc.
  • Sensirion AG
  • Strados Labs, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vitalograph Ltd.
Product Code: MRR-9A6A6F29743D

The Asthma Monitoring Devices Market was valued at USD 2.05 billion in 2025 and is projected to grow to USD 2.22 billion in 2026, with a CAGR of 8.94%, reaching USD 3.73 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.05 billion
Estimated Year [2026] USD 2.22 billion
Forecast Year [2032] USD 3.73 billion
CAGR (%) 8.94%

An authoritative overview of how digital sensing, regulatory rigor, and care delivery shifts are reshaping clinical and consumer approaches to asthma monitoring devices

Asthma monitoring devices now sit at the nexus of clinical need, digital innovation, and consumer health engagement. Rapid advances in sensing technologies, connectivity protocols, and user-centered design have redefined how clinicians and patients monitor respiratory function and manage chronic conditions. In a landscape where adherence and early detection directly influence clinical outcomes, devices such as smart inhalers and wearable monitors are no longer adjuncts but integral components of care pathways.

As healthcare systems emphasize value-based care and remote management, stakeholders increasingly demand evidence that devices deliver actionable, interoperable, and secure data streams. At the same time, regulatory scrutiny around data privacy, device validation, and clinical utility has intensified, prompting manufacturers to invest in rigorous clinical validation and robust cybersecurity measures. Collectively, these forces are reshaping procurement preferences, partnership models, and go-to-market strategies.

Consequently, organizations must navigate a dense and evolving environment that blends medical device engineering, cloud connectivity, and behavioral science. This introduction sets the stage for a deeper analysis of disruptive shifts, regulatory and trade headwinds, segmentation dynamics, and regional considerations that together determine how asthma monitoring technologies are adopted, scaled, and integrated across care settings.

How sensor miniaturization, smartphone integration, remote care priorities, and data governance are driving a fundamental reconfiguration of asthma monitoring value chains

The landscape for asthma monitoring devices is undergoing transformative shifts driven by converging forces in technology, healthcare delivery, and patient expectations. Advances in miniaturized sensors and low-power wireless protocols have enabled a new generation of devices that capture continuous physiologic data while minimizing user burden. In parallel, improvements in smartphone integration and cloud-based analytics have increased the practical value of device-generated data by enabling trend detection, automated alerts, and integration with electronic health records.

Meanwhile, healthcare delivery reforms favoring remote patient monitoring and chronic disease management have opened new channels for device deployment beyond traditional clinical settings. Payers and providers are also incentivizing outcomes-focused solutions, which increases demand for devices that can demonstrate real-world clinical impact and adherence improvements. In response, manufacturers are shifting from selling hardware to delivering end-to-end solutions that combine devices, software, and services.

Crucially, interoperability and data governance have moved from optional considerations to core requirements. Regulators and healthcare customers expect devices to meet stringent privacy standards and to provide transparent evidence for their algorithms. As a result, partnerships between device makers, digital health platforms, and clinical organizations are becoming the norm, and companies that can marry technological sophistication with clinical validation and operational scalability will lead the next wave of adoption.

Assessing how 2025 tariff changes reconfigured supply chains, procurement calculus, and supplier strategies across the asthma monitoring device ecosystem

The introduction of cumulative tariff measures in 2025 created immediate and cascading effects across supply chains and procurement strategies for medical devices. Manufacturers that rely on cross-border sourcing of electronic components, housings, and sensors experienced increased input costs and longer lead times. In response, some firms diversified their supplier base and accelerated supplier qualification processes, while others re-evaluated the tradeoffs between onshore production and offshore cost advantages.

These trade policy shifts also influenced pricing strategies and contract negotiations with distributors and healthcare purchasers. Procurement professionals faced new considerations around total landed cost, warranty terms, and inventory buffering to insure against future tariff volatility. Consequently, device makers with vertically integrated capabilities or localized assembly footprints had a relative advantage in maintaining predictable delivery schedules and negotiating stable pricing with institutional buyers.

Moreover, the broader commercial environment prompted greater emphasis on supply chain transparency and scenario planning. Companies invested in dual-sourcing strategies, enhanced inventory visibility tools, and supplier risk assessments to mitigate the impact of future tariff movements. Taken together, these developments reinforced the importance of resilient operations and adaptive commercial models in ensuring continued access to critical monitoring technologies for patients and clinicians.

Deep segmentation insights revealing how product types, connectivity choices, distribution routes, power design, clinical applications, age cohorts, and end users determine adoption pathways

A granular view of device categories and deployment contexts reveals distinct adoption dynamics across product, technology, distribution, power, application, age group, and end-user segments. Product types range from electronic asthma monitors, peak flow meters, pulse oximeters, smart inhalers, and spirometers to wearable monitoring devices; within wearables, heart rate sensors, oxygen saturation sensors, and respiratory rate sensors support diverse clinical use cases and differing validation requirements. These devices are increasingly built on either connected architectures or smartphone-integrated models; the connected category further subdivides into Bluetooth, cellular, and Wi-Fi modalities, each affecting interoperability, data latency, and power consumption.

Distribution pathways include direct sales to institutional buyers, hospital pharmacies, online pharmacies, and retail pharmacies, with retail further divided into brick-and-mortar and online marketplace channels that influence customer acquisition and after-sales support. Power options-battery-operated, plug-in electric, and rechargeable-shape usability and lifecycle costs across home and clinical settings. Application domains encompass support for asthma diagnosis, daily symptom tracking, medication adherence monitoring, pulmonary function assessment, and remote patient monitoring, and these applications often determine required regulatory evidence and integration needs.

Age group segmentation differentiates adults, geriatric patients, and pediatrics, which in turn affects form factor, usability testing, and clinical endpoints. Finally, end users such as ambulatory surgical centers, diagnostic laboratories, homecare settings, hospitals and clinics, and research and academic institutes have unique procurement cycles, technical requirements, and support expectations. Understanding how these overlapping segments interact enables more precise product positioning and commercialization strategies.

Comparative regional analysis highlighting how regulatory frameworks, payer models, manufacturing capacity, and healthcare priorities shape device adoption across global regions

Regional dynamics exert a powerful influence on regulatory pathways, reimbursement models, and adoption tempo across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong hospital networks and growing payer interest in value-based care accelerate demand for devices that can demonstrate clinical utility and support remote management, while private-sector innovation ecosystems foster consumer-facing device development. Transitioning from early adopters to broader institutional uptake often depends on evidence generation and integration with provider IT systems.

In Europe, Middle East & Africa, regulatory frameworks emphasize device safety and data protection, and regional fragmentation in reimbursement creates heterogeneous uptake patterns that favor devices adaptable to multiple payer environments. Additionally, several markets in the region prioritize public procurement, which places a premium on cost transparency and long-term service agreements. Meanwhile, Asia-Pacific presents a mix of advanced digital health initiatives and high-volume manufacturing capacity; policy emphasis on domestic capability building and public health programs can create large-scale deployment opportunities for cost-effective devices that meet local regulatory standards.

Across regions, interoperability standards, clinician workflows, and consumer preferences vary significantly, which means global product strategies must be tailored to local regulatory requirements, distribution ecosystems, and procurement behaviors. Successful regional entry plans emphasize partnerships, localized clinical validation, and flexible commercial models that accommodate unique payer and customer landscapes.

Competitive landscape intelligence showing how clinical credibility, digital-first entrants, partnerships, and service-oriented models are redefining differentiation and scale-up strategies

Competitive dynamics in the asthma monitoring devices landscape are characterized by a mix of established medical device firms, nimble digital health startups, and vertically integrated companies that combine hardware, software, and services. Incumbent manufacturers often leverage clinical credibility, regulatory experience, and established distribution networks to maintain relationships with hospitals and diagnostic centers. Conversely, newer entrants frequently focus on user experience, rapid iteration, and cloud-enabled analytics to capture attention in consumer and outpatient segments.

Strategic partnerships and M&A activity have emerged as common pathways to scale, enabling device makers to pair clinical-grade hardware with advanced data platforms, telehealth providers, or pharmacy channels. Companies that prioritize clinical validation, interoperability, and post-market support gain traction with institutional buyers who demand predictable performance and integration with electronic health systems. At the same time, firms that invest in robust cybersecurity measures and transparent algorithmic performance build trust with both clinicians and regulators.

Service models that bundle devices with subscription-based analytics, adherence programs, and clinician dashboards are becoming more prevalent, as they align vendor incentives with clinical outcomes. Ultimately, competitive advantage flows to organizations that can demonstrate not only product reliability and clinical value but also operational scalability and a clear path to integration within care delivery workflows.

Practical and prioritized strategic steps for device makers and health system leaders to build clinical credibility, interoperability, resilient supply chains, and flexible commercial models

Industry leaders should pursue a pragmatic set of actions to convert technological promise into durable clinical and commercial outcomes. First, prioritize rigorous clinical validation across representative patient cohorts to build trust with clinicians and payers; invest in prospective studies and real-world evidence collection that focus on adherence, exacerbation reduction, and care coordination metrics. Second, design devices and platforms for interoperability by adopting open standards and providing well-documented APIs to facilitate integration with electronic health records and telehealth services.

Third, strengthen supply chain resilience by diversifying component suppliers, qualifying alternative manufacturing sites, and implementing transparent inventory monitoring to reduce exposure to trade policy shocks. Fourth, offer flexible commercial models that include bundled services, outcome-linked contracts, and tiered licensing to align value capture with payer and provider incentives. Fifth, embed privacy and cybersecurity by design, ensuring encryption, secure device provisioning, and clear data governance to meet regulatory expectations and stakeholder requirements.

Finally, cultivate cross-sector partnerships with pharmacies, payers, and clinical networks to expand distribution channels and support adoption. By sequentially addressing clinical credibility, technical interoperability, operational resilience, and commercial flexibility, leaders can accelerate sustainable adoption while reducing friction for institutional and consumer customers alike.

A transparent, multi-source research approach combining stakeholder interviews, clinical validation review, technical assessments, and supply chain scenario analysis to ensure rigorous findings

This study synthesizes primary and secondary research with a structured approach to evidence and quality assurance. Primary inputs include interviews with clinical leaders, procurement professionals, device engineers, and payer representatives, supplemented by technical evaluations of device specifications, regulatory filings, and product literature. Secondary sources encompass peer-reviewed clinical studies, regulatory guidance documents, and publicly available product information, which were triangulated to validate device capabilities and typical deployment scenarios.

Analytical methods included qualitative thematic analysis of stakeholder interviews, comparative assessment of device feature sets and connectivity profiles, and scenario-based supply chain risk mapping to understand operational sensitivities. Special attention was given to clinical validation requirements and interoperability standards to reflect real-world integration challenges. Throughout, findings were cross-checked by domain experts to ensure technical accuracy and to contextualize commercial implications.

Limitations and caveats are acknowledged, including variability in clinical adoption timelines across regions and the evolving regulatory landscape. To mitigate bias, multiple sources were used to corroborate claims, and key assumptions were made explicit in internal documentation. This methodology supports rigor while remaining adaptable to new evidence and regulatory updates.

A synthesis emphasizing that validated sensing, interoperability, supply chain resilience, and aligned commercial models form the foundation for sustainable adoption and clinical impact

In conclusion, asthma monitoring devices are at an inflection point where technological capability, clinical demand for remote management, and evolving procurement dynamics converge to create new opportunities and obligations for manufacturers, providers, and payers. Devices that combine validated sensing, seamless connectivity, and demonstrable clinical utility will earn preference among institutional buyers, while consumer-focused solutions must balance ease of use with clinical data fidelity.

Operational resilience and regulatory readiness are now central to commercial viability; organizations that proactively address supply chain vulnerability, data governance, and interoperability will face fewer barriers to adoption. Moreover, cross-sector partnerships that blend clinical expertise, pharmacy reach, and digital health services will likely accelerate scalable deployment across care settings. As a result, the strategic focus should be on delivering measurable clinical outcomes, enabling integration with care workflows, and creating commercial models that align incentives across stakeholders.

Taken together, these imperatives create a roadmap for industry participants seeking to translate innovation into sustained impact: validate rigorously, design for integration, secure supply continuity, and align commercial terms to support clinical adoption and patient benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Asthma Monitoring Devices Market, by Product Type

  • 8.1. Electronic Asthma Monitor
  • 8.2. Peak Flow Meter
  • 8.3. Pulse Oximeter
  • 8.4. Smart Inhalers
  • 8.5. Spirometer
  • 8.6. Wearable Monitoring Device
    • 8.6.1. Heart Rate Sensor
    • 8.6.2. Oxygen Saturation Sensor
    • 8.6.3. Respiratory Rate Sensor

9. Asthma Monitoring Devices Market, by Technology

  • 9.1. Connected
    • 9.1.1. Bluetooth
    • 9.1.2. Cellular
    • 9.1.3. Wi-Fi
  • 9.2. Smartphone Integrated

10. Asthma Monitoring Devices Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Hospital Pharmacy
  • 10.3. Online Pharmacy
  • 10.4. Retail Pharmacy
    • 10.4.1. Brick And Mortar
    • 10.4.2. Online Marketplace

11. Asthma Monitoring Devices Market, by Power Source

  • 11.1. Battery-Operated
  • 11.2. Plug-In Electric
  • 11.3. Rechargeable

12. Asthma Monitoring Devices Market, by Application

  • 12.1. Asthma Diagnosis Support
  • 12.2. Daily Symptom Tracking
  • 12.3. Medication Adherence Monitoring
  • 12.4. Pulmonary Function Monitoring
  • 12.5. Remote Patient Monitoring (RPM)

13. Asthma Monitoring Devices Market, by Age Group

  • 13.1. Adults
  • 13.2. Geriatric
  • 13.3. Pediatrics

14. Asthma Monitoring Devices Market, by End User

  • 14.1. Ambulatory Surgical Centers (ASCs)
  • 14.2. Diagnostic Laboratories
  • 14.3. Homecare Settings
  • 14.4. Hospitals & Clinics
  • 14.5. Research & Academic Institutes

15. Asthma Monitoring Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Asthma Monitoring Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Asthma Monitoring Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Asthma Monitoring Devices Market

19. China Asthma Monitoring Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. 3M Company
  • 20.6. Adherium Limited
  • 20.7. Amiko Digital Health Limited
  • 20.8. AptarGroup, Inc.
  • 20.9. AstraZeneca plc
  • 20.10. FindAir
  • 20.11. Health Care Originals, Inc.
  • 20.12. Koninklijke Philips N.V.
  • 20.13. Masimo Corporation
  • 20.14. MGC Diagnostics Corporation
  • 20.15. Microlife Corporation
  • 20.16. Nihon Kohden Corporation
  • 20.17. Novartis AG
  • 20.18. Omron Healthcare, Inc.
  • 20.19. Sensirion AG
  • 20.20. Strados Labs, Inc.
  • 20.21. Teva Pharmaceutical Industries Ltd.
  • 20.22. Vitalograph Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ASTHMA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ASTHMA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ELECTRONIC ASTHMA MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ELECTRONIC ASTHMA MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ELECTRONIC ASTHMA MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEAK FLOW METER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEAK FLOW METER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEAK FLOW METER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULSE OXIMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULSE OXIMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULSE OXIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SPIROMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SPIROMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SPIROMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HEART RATE SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HEART RATE SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HEART RATE SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY OXYGEN SATURATION SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY OXYGEN SATURATION SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY OXYGEN SATURATION SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESPIRATORY RATE SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESPIRATORY RATE SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESPIRATORY RATE SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMARTPHONE INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMARTPHONE INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMARTPHONE INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BRICK AND MORTAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BRICK AND MORTAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BRICK AND MORTAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE MARKETPLACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE MARKETPLACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE MARKETPLACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BATTERY-OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BATTERY-OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BATTERY-OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PLUG-IN ELECTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PLUG-IN ELECTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PLUG-IN ELECTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ASTHMA DIAGNOSIS SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ASTHMA DIAGNOSIS SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ASTHMA DIAGNOSIS SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DAILY SYMPTOM TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DAILY SYMPTOM TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DAILY SYMPTOM TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY MEDICATION ADHERENCE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY MEDICATION ADHERENCE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY MEDICATION ADHERENCE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULMONARY FUNCTION MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULMONARY FUNCTION MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULMONARY FUNCTION MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING (RPM), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING (RPM), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING (RPM), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 226. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 257. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 259. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 261. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 262. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 264. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 270. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 272. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 275. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)